全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

An Optically Controlled 3D Cell Culturing System

DOI: 10.1155/2011/253989

Full-Text   Cite this paper   Add to My Lib

Abstract:

A novel 3D cell culture system was developed and tested. The cell culture device consists of a microfluidic chamber on an optically absorbing substrate. Cells are suspended in a thermoresponsive hydrogel solution, and optical patterns are utilized to heat the solution, producing localized hydrogel formation around cells of interest. The hydrogel traps only the desired cells in place while also serving as a biocompatible scaffold for supporting the cultivation of cells in 3D. This is demonstrated with the trapping of MDCK II and HeLa cells. The light intensity from the optically induced hydrogel formation does not significantly affect cell viability. 1. Introduction Drug- and cell-based therapies are being explored for many medical conditions [1, 2], including heart disease [3], cancer [4–6], and diabetes [7–9]. However, the process of identifying suitable treatments is long and complicated. The time from drug discovery to Food and Drug Administration approval is usually 10 to 15 years [10], costing from $800 million to $1 billion [11]. Numerous processes contribute to this long lead time, including the testing of drug compounds, drug effects, and drug safety. These tests are conducted in order of increasing complexity: biochemical assays, cell-based assays, animal models, and then clinical trials. It is possible to simplify this testing procedure with improved cell-based assays that could enable the reduction or elimination of animal testing, reducing the time and cost of developing new drugs. Cell-based drug assays can be improved by culturing cells in vitro that remain highly representative of their in vivo counterparts, resulting in more realistic testing results, mitigating the risks and costs associated with testing on live subjects, while accelerating the development process. Recent evidence suggests that 3D cultures are more representative of cellular behavior as compared to 2D cultures [12], as 3D cultures more closely simulate in vivo cellular microenvironments [13]. For example, cancerous cells grown in 3D cultures are more resistant to drugs versus cells in 2D cultures [14, 15]. 3D cultures have been developed where cells are seeded on porous biomaterials [10, 15, 16] or scaffold-like microstructures [17–19]. Integration of these materials in microfluidic systems can facilitate diffusive transfer of nutrients and waste and minimizes the use of materials and reagents, thereby lowering costs and increasing parallelization of culturing and testing [10, 20]. Thus, appropriately designed microdevices can greatly improve the predictive value of

References

[1]  A. Dove, “Cell-based therapies go live,” Nature Biotechnology, vol. 20, no. 4, pp. 339–343, 2002.
[2]  K. H. Wilan, C. T. Scott, and S. Herrera, “Chasing a cellular fountain of youth,” Nature Biotechnology, vol. 23, no. 7, pp. 807–815, 2005.
[3]  V. F. M. Segers and R. T. Lee, “Stem-cell therapy for cardiac disease,” Nature, vol. 451, no. 7181, pp. 937–942, 2008.
[4]  W. Xu, L. Liu, and I. G. Charles, “Microencapsulated iNOS-expressing cells cause tumor suppression in mice,” The FASEB Journal, vol. 16, no. 2, pp. 213–215, 2002.
[5]  M. E. Dudley and S. A. Rosenberg, “Adoptive-cell-transfer therapy for the treatment of patients with cancer,” Nature Reviews Cancer, vol. 3, no. 9, pp. 666–675, 2003.
[6]  L. Gattinoni, D. J. Powell, S. A. Rosenberg, and N. P. Restifo, “Adoptive immunotherapy for cancer: building on success,” Nature Reviews Immunology, vol. 6, no. 5, pp. 383–393, 2006.
[7]  Y. Sun, X. Ma, D. Zhou, I. Vacek, and A. M. Sun, “Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression,” Journal of Clinical Investigation, vol. 98, no. 6, pp. 1417–1422, 1996.
[8]  T. Sapir, K. Shternhall, I. Meivar-Levy et al., “Cell-replacement therapy for diabetes: generating functional insulin-producing tissue from adult human liver cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 22, pp. 7964–7969, 2005.
[9]  J. J. Meier, A. Bhushan, and P. C. Butler, “The potential for stem cell therapy in diabetes,” Pediatric Research, vol. 59, no. 4, pp. 65R–73R, 2006.
[10]  M. H. Wu, S. B. Huang, and G. B. Lee, “Microfluidic cell culture systems for drug research,” Lab on a Chip, vol. 10, no. 8, pp. 939–956, 2010.
[11]  Pharmaceutical Research and Manufacturers of America, Pharmaceutical Industry Profile2011, PhRMA, Washington, DC, USA, 2011, http://www.phrma.org/.
[12]  U. Marx and V. Sandig, Drug Testing In Vitro: Breakthroughs and Trends in Cell Culture Technology, Wiley-VCH, Weinheim, Germany, 2007.
[13]  J. El-Ali, P. K. Sorger, and K. F. Jensen, “Cells on chips,” Nature, vol. 442, no. 7101, pp. 403–411, 2006.
[14]  Y. S. Torisawa, H. Shiku, T. Yasukawa, M. Nishizawa, and T. Matsue, “Multi-channel 3-D cell culture device integrated on a silicon chip for anticancer drug sensitivity test,” Biomaterials, vol. 26, no. 14, pp. 2165–2172, 2005.
[15]  D. W. Hutmacher, “Biomaterials offer cancer research the third dimension,” Nature Materials, vol. 9, no. 2, pp. 90–93, 2010.
[16]  B. A. Justice, N. A. Badr, and R. A. Felder, “3D cell culture opens new dimensions in cell-based assays,” Drug Discovery Today, vol. 14, no. 1-2, pp. 102–107, 2009.
[17]  R. C. Dutta and A. K. Dutta, “Cell-interactive 3D-scaffold; advances and applications,” Biotechnology Advances, vol. 27, no. 4, pp. 334–339, 2009.
[18]  L. H. Han, G. Mapili, S. Chen, and K. Roy, “Projection microfabrication of three-dimensional scaffolds for tissue engineering,” Journal of Manufacturing Science and Engineering, vol. 130, no. 2, article 021005, 4 pages, 2008.
[19]  V. Chan, P. Zorlutuna, J. H. Jeong, H. Kong, and R. Bashir, “Three-dimensional photopatterning of hydrogels using stereolithography for long-term cell encapsulation,” Lab on a Chip, vol. 10, no. 16, pp. 2062–2070, 2010.
[20]  P. S. Dittrich and A. Manz, “Lab-on-a-chip: microfluidics in drug discovery,” Nature Reviews Drug Discovery, vol. 5, no. 3, pp. 210–218, 2006.
[21]  V. L. Tsang and S. N. Bhatia, “Three-dimensional tissue fabrication,” Advanced Drug Delivery Reviews, vol. 56, no. 11, pp. 1635–1647, 2004.
[22]  M. J. Powers, K. Domansky, M. R. Kaazempur-Mofrad et al., “A microfabricated array bioreactor for perfused 3D liver culture,” Biotechnology and Bioengineering, vol. 78, no. 3, pp. 257–269, 2002.
[23]  S. A. Lee, S. E. Chung, W. Park, S. H. Lee, and S. Kwon, “Three-dimensional fabrication of heterogeneous microstructures using soft membrane deformation and optofluidic maskless lithography,” Lab on a Chip, vol. 9, no. 12, pp. 1670–1675, 2009.
[24]  D. R. Albrecht, G. H. Underhill, T. B. Wassermann, R. L. Sah, and S. N. Bhatia, “Probing the role of multicellular organization in three-dimensional microenvironments,” Nature Methods, vol. 3, no. 5, pp. 369–375, 2006.
[25]  T. Braschler, R. Johann, M. Heule, L. Metref, and P. Renaud, “Gentle cell trapping and release on a microfluidic chip by in situ alginate hydrogel formation,” Lab on a Chip, vol. 5, no. 5, pp. 553–559, 2005.
[26]  Y. H. Bae, T. Okano, and S. Wan Kim, “Temperature dependence of swelling of crosslinked poly(N,N'-alkyl substituted acrylamides) in water,” Journal of Polymer Science B, vol. 28, no. 6, pp. 923–936, 1990.
[27]  R. A. Stile, W. R. Burghardt, and K. E. Healy, “Synthesis and characterization of injectable poly(N-isopropylacrylamide)-based hydrogels that support tissue formation in vitro,” Macromolecules, vol. 32, no. 22, pp. 7370–7379, 1999.
[28]  J. F. Pollock and K. E. Healy, “Mechanical and swelling characterization of poly(N-isopropyl acrylamide -co- methoxy poly(ethylene glycol) methacrylate) sol-gels,” Acta Biomaterialia, vol. 6, no. 4, pp. 1307–1318, 2010.
[29]  D. G. Grier, “A revolution in optical manipulation,” Nature, vol. 424, no. 6950, pp. 810–816, 2003.
[30]  S. K. Mohanty, A. Rapp, S. Monajembashi, P. K. Gupta, and K. O. Greulich, “Comet assay measurements of DNA damage in cells by laser microbeams and trapping beams with wavelengths spanning a range of 308?nm to 1064?nm,” Radiation Research, vol. 157, no. 4, pp. 378–385, 2002.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133